Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. Post author:Sam Post published:December 18, 2017 Post category:BioPharma The FDA broke new ground today with a first-of-its-kind therapy for eye disease. Source: BioSpace You Might Also Like Kindred Bio To Announce Second Quarter 2017 Financial Results July 23, 2017 <b>EBS Technologies</b> Appoints <b>Karl Schweitzer</b> As Chief Executive Officer August 27, 2017 Novartis AG to Shed Another 500 Jobs, Add 350 High-Tech Jobs May 18, 2017
